ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,814.40
-0.85%
S&P ASX All Technology
3,045.20
-2.07%
Brent Oil
83.76
0.67%
US Dollar vs AUD
1.49209
-0.31%
Bitcoin
66,786.75
2.37%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Ligand Pharmaceuticals Incorporated (PK) (LGNZZ)

  7. Ligand Pharmaceuticals Incorporated (PK) (LGNZZ) News

LGNZZ

Ligand Pharmaceuticals (PK) (LGNZZ)

Ligand Pharmaceuticals Incorporated (PK)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:LGNZZ
DateTimeSourceHeadlineSymbolCompany
14/05/202408:14Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
14/05/202407:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
10/05/202408:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
10/05/202408:03Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
09/05/202406:07Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
08/05/202406:03Edgar (US Regulatory)Form 8-K - Current reportUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
07/05/202421:36Edgar (US Regulatory)Form 8-K - Current reportUSOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
06/06/202006:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
09/05/202006:29Edgar (US Regulatory)Quarterly Report (10-q)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
07/05/202006:03Edgar (US Regulatory)Current Report Filing (8-k)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
25/04/202009:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
25/04/202009:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
25/04/202009:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
25/04/202006:10Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
25/04/202006:07Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
08/04/202006:41Edgar (US Regulatory)Current Report Filing (8-k)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
07/04/202007:16Edgar (US Regulatory)Current Report Filing (8-k)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
03/04/202007:19Edgar (US Regulatory)Current Report Filing (8-k)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
14/03/202009:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
28/02/202009:38Edgar (US Regulatory)Annual Report (10-k)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
19/02/202009:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
19/02/202009:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
19/02/202009:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
19/02/202009:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
15/02/202005:19Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
15/02/202003:34Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
15/02/202002:04Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
14/02/202023:45Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
14/02/202003:09Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
13/02/202000:10Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:LGNZZLigand Pharmaceuticals Incorporated (PK)
 Showing the most relevant articles for your search:USOTC:LGNZZ

Your Recent History

LSE
72GT
LSE
FN24
Ebrd.24
BIT
O8JNV6
Morgan Stanley Bv
LSE
CAGB
Etf S Cad L Gbp
LSE
NBV
Noble Vct
LSE
EDIN
Edinburgh Investment
KRKN
ZECXBT
LSE
47IE
S & U 31.5%pf
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved